Brief: Lipocine Announces Distribution And License Agreement With SPC Korea To Commercialize TLANDO In South Korea
31/10/2024 12:37
Oct 31 (Reuters) - Lipocine Inc LPCN.O :
* LIPOCINE ANNOUNCES DISTRIBUTION AND LICENSE AGREEMENT WITH
SPC
KOREA TO COMMERCIALIZE TLANDO® IN SOUTH KOREA
* LIPOCINE INC - TO RECEIVE UPFRONT PAYMENT AND MILESTONE
PAYMENTS
Source text: ID:nPn9rFpZ4a
Further company coverage: LPCN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lipocine
See all newsUS STOCKS ON THE MOVE-Halozyme, Moderna, Merck
U.S. STOCKS ON THE MOVE-Halozyme, BKV, AppFolio
U.S. STOCKS ON THE MOVE-Hecla Mining, XPO, Lipocine
Lipocine surges after Canada approves co's testosterone replacement therapy
Brief: Lipocine Announces Health Canada Approval Of Tlando For Testosterone Replacement Therapy